Characteristics of sars-coV-2 and covid-19

7, 154 (2018).
37
. Lau, S. K. P. et al. Possible bat origin of severe acute 
respiratory syndrome coronavirus 2. Emerg. Infect. Dis. 
26, 1542–1547 (2020).
38
. Zhang, Y. Z. & Holmes, E. C. A genomic perspective
on the origin and emergence of SARS- CoV-2. Cell 181, 
223–227 (2020).
39
. Lam, T. T. et al. Identifying SARS- CoV-2 related 
coronaviruses in Malayan pangolins. Nature 583, 
282–285 (2020).
40
. Xiao, K. et al. Isolation of SARS- CoV-2-related 
coronavirus from Malayan pangolins. Nature 583, 
286–289 (2020).
41
. Liu, P., Chen, W. & Chen, J. P. Viral metagenomics 
revealed Sendai virus and coronavirus infection of 
Malayan pangolins (Manis javanica). Viruses 11, 979 
(2019).
42
. Zhang, T., Wu, Q. & Zhang, Z. Probable pangolin 
origin of SARS- CoV-2 associated with the COVID-19 
outbreak. Curr. Biol. 30, 1346–1351 (2020).
43
. Shi, J. et al. Susceptibility of ferrets, cats, dogs, and 
other domesticated animals to SARS- coronavirus 2. 
Science
368, 1016–1020 (2020).
44
. Oreshkova, N. et al. SARS- CoV-2 infection in farmed 
minks, the Netherlands, April and May 2020. Euro 
Surveill.
25, 2001005 (2020).
45
. Sit, T. H. C. et al. Infection of dogs with SARS- CoV-2. 
Nature
 
https://doi.org/10.1038/s41586-020-2334-5
(2020).
46
. Zhang, Q. et al. A serological survey of SARS- CoV-2 in 
cat in Wuhan. Emerg. Microbes Infect. 
https://doi.org/
10.1080/22221751.2020.1817796
(2020).
47
. Hoffmann, M. et al. SARS- CoV-2 cell entry depends
on ACE2 and TMPRSS2 and is blocked by a clinically 
proven protease inhibitor. Cell 181, 271–280 
(2020).
48
. Chandrashekar, A. et al. SARS- CoV-2 infection protects 
against rechallenge in rhesus macaques. Science 369, 
812–817 (2020).
49
. Zhao, X. et al. Broad and differential animal 
angiotensin- converting enzyme 2 receptor usage by 
SARS- CoV-2. J. Virol. 94, e00940-20 (2020).
50
. Shang, J. et al. Structural basis of receptor recognition 
by SARS- CoV-2. Nature 581, 221–224 (2020).
51
. Walls, A. C. et al. Structure, function, and antigenicity 
of the SARS- CoV-2 spike glycoprotein. Cell 181,
281–292 (2020).
52
. Wan, Y., Shang, J., Graham, R., Baric, R. S. & Li, F. 
Receptor recognition by the novel coronavirus from 
Wuhan: an analysis based on decade- long structural 
studies of SARS coronavirus. J. Virol. 94, e00127-20 
(2020).
53
. Letko, M., Marzi, A. & Munster, V. Functional 
assessment of cell entry and receptor usage for SARS- 
CoV-2 and other lineage B betacoronaviruses. Nat. 
Microbiol.
5, 562–569 (2020).
54
. Ou, X. et al. Characterization of spike glycoprotein
of SARS- CoV-2 on virus entry and its immune cross- 
reactivity with SARS- CoV. Nat. Commun. 11, 1620 
(2020).
55
. Shang, J. et al. Cell entry mechanisms of SARS- CoV-2. 
Proc. Natl Acad. Sci. USA
117, 11727–11734 (2020).
56
. Sungnak, W. et al. SARS- CoV-2 entry factors are
highly expressed in nasal epithelial cells together with 
innate immune genes. Nat. Med. 26, 681–687 
(2020).
57
. Lukassen, S. et al. SARS- CoV-2 receptor ACE2 and 
TMPRSS2 are primarily expressed in bronchial 
transient secretory cells. EMBO. J. 39, e105114 
(2020).
58
. Wrapp, D. et al. Cryo- EM structure of the 2019-nCoV 
spike in the prefusion conformation. Science 367, 
1260–1263 (2020).
59
. Yuan, Y. et al. Cryo- EM structures of MERS- CoV and 
SARS- CoV spike glycoproteins reveal the dynamic 
receptor binding domains. Nat. Commun. 8, 15092 
(2017).
60
. Huang, C. et al. Clinical features of patients infected 
with 2019 novel coronavirus in Wuhan, China. Lancet